Dimethylamine → (5-Bromo-imidazo[1,2-a]pyrazin-8-yl)-(3-dimethylaminomethyl-4-morpholin-4-yl-phenyl)-carbamic acid tert-butyl ester

HRID 1366225노트

반응식

HRID 1366225 반응식
[Br:1][C:2]1[N:7]2[CH:8]=[CH:9][N:10]=[C:6]2[C:5]([N:11]([C:30]([O:32][C:33]([CH3:36])([CH3:35])[CH3:34])=[O:31])[C:12]2[CH:13]=[CH:14][C:15]([N:24]3[CH2:29][CH2:28][O:27][CH2:26][CH2:25]3)=[C:16]([CH:23]=2)[CH2:17]OS(C)(=O)=O)=[N:4][CH:3]=1.[CH3:37][NH:38][CH3:39].C([O-])([O-])=O.[K+].[K+]>C1COCC1>[NH3:4].[C:33]([O:32][C:30](=[O:31])[N:11]([C:5]1[C:6]2[N:7]([CH:8]=[CH:9][N:10]=2)[C:2]([Br:1])=[CH:3][N:4]=1)[C:12]1[CH:13]=[CH:14][C:15]([N:24]2[CH2:25][CH2:26][O:27][CH2:28][CH2:29]2)=[C:16]([CH2:17][N:38]([CH3:39])[CH3:37])[CH:23]=1)([CH3:35])([CH3:34])[CH3:36]

참가 물질

6

반응 조건

온도
75 °C

실험 절차

To a solution of methanesulfonic acid 5-[(5-bromo-imidazo[1,2-a]pyrazin-8-yl)-tert-butoxycarbonyl-amino]-2-morpholin-4-yl-benzyl ester (0.098 g, 0.169 mmol) in THF (0.5 mL) is added 2M N,N-dimethylamine solution in THF (0.50 mL, 1.1 mmol) followed by K2CO3 (0.028 g, 0.202 mmol). The reaction mixture is stirred at room temperature for 1.5 hours and at 75° C. for an additional 3 hours. The solvent is removed under vacuum and the residue is partitioned between ethyl acetate and water. The organic layer is dried over MgSO4, filtered and concentrated in vacuo to give the crude compound which is purified by silica gel column chromatography. Elution using 97:3 DCM:NH3 (7M in MeOH) affords the title compound (0.0543 g, 61%). LCMS: Rt 2.37 min (95%), m/z (ES+) 531/533 (M+H)+.

후처리

  1. customThe solvent is removed under vacuum
  2. customthe residue is partitioned between ethyl acetate and water
  3. dry with materialThe organic layer is dried over MgSO4
  4. filtrationfiltered
  5. concentrationconcentrated in vacuo
  6. customto give the crude compound which
  7. customis purified by silica gel column chromatography
  8. washElution

출처 및 근거

ORD 기록
ord-ad74bbcd91fe45c48ca511293daa9486
출처 데이터셋
uspto-grants-2011_02
특허 번호
US07893058B2

반응 노트

불러오는 중…